Newman Mark J

Avg. Two Year Performance

(70%) Avg. Purchase Return
(30%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(9%)(32%)(73%)(65%)(70%)
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 3.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Vice President, R&D:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--